Inventor · disambiguated record
Nicole Cathleen Goodwin
Also filed as: GOODWIN NICOLE CATHLEEN
12 granted patents·5 pending applications·33 citations·filing 2008–2024
88Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD7LEXICON PHARMACEUTICALS INC4ASTEX THERAPEUTICS LTD2BURGOON HUGH ALFRED2GOODWIN NICOLE CATHLEEN2
Top patents by PatentIndex Score
17 records- 0187US10106569B2Inhibitors of sodium glucose transporter 1 for constipationLEXICON PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·5 cites·1 claims
- 0287US9688710B2Inhibitors of sodium glucose cotransporter 1LEXICON PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·5 cites·8 claims
- 0386US8026347B2Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitorsLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Sep 27, 2011·9 cites·42 claims
- 0485US9200025B2Inhibitors of sodium glucose cotransporter 1LEXICON PHARMACEUTICALS INC·Filed 2013·Granted Dec 1, 2015·7 cites·15 claims
- 0582US10604509B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 31, 2020·2 cites·26 claims
- 0681US2025084077A1Ether linked triazoles as nrf2 activatorsASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0773US8193202B2LIMK2 inhibitors, compositions comprising them, and methods of their useBURGOON HUGH ALFRED·Filed 2009·Granted Jun 5, 2012·2 cites·7 claims
- 0869US12091409B2Ether linked triazoles as NRF2 activatorsASTEX THERAPEUTICS LTD·Filed 2021·Granted Sep 17, 2024·0 cites·9 claims
- 0969US8293878B2Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitorsGOODWIN NICOLE CATHLEEN·Filed 2011·Granted Oct 23, 2012·2 cites·14 claims
- 1069US2023047296A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 1166US8450332B2LIMK2 inhibitors, compositions comprising them, and methods of their useBURGOON HUGH ALFRED·Filed 2012·Granted May 28, 2013·1 cites·7 claims
- 1264US11059816B2Ether linked triazoles as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jul 13, 2021·0 cites·4 claims
- 1358US2020079759A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 1454US11117905B2Bisaryl heterocycles as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Sep 14, 2021·0 cites·10 claims
- 1540US2022002272A1Bisaryl lactams as nrf2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1638US2013059896A15-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eyeGOODWIN NICOLE CATHLEEN·Filed 2011·Application pending·0 cites
- 1737US11078216B2Bisaryl amides as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Aug 3, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Nicole Cathleen Goodwin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →